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There are now numerous examples of suppressor molecules released by mouse T 
cells.  Both  specific  and  nonspecific  factors,  regulating  humoral  or  cell-mediated 
responses, have been identified and partially characterized (1-15). In some cases, the 
factors express determinants encoded by genes in the I region of the major histocom- 
patibility complex (MHC) 1 (3), specifically the I-J (7-9,  11), or I-C region (15). The 
precise role of these Ia determinants in the factor-mediated suppression is not clear. 
In  at  least  two  instances,  however,  it  appears  that  they  interact  with  acceptor 
molecules encoded by the  homologous I  region  on  the  target  cell(s)  (16-19),  thus 
imparting a genetic restriction on the action of the suppressor molecules. The nature 
of this interaction, i.e., like-like or lock-and-key, has not been established. 
Previous papers in this series have described a soluble suppressor factor (SSF) which 
suppresses contact sensitivity (CS) to 2,4-dinitrofluorobenzene (DNFB)  (20, 21). This 
factor is released in vitro by cultures of suppressor T  cell-containing lymph node (LN) 
cells from DNFB-tolerant mice. SSF is antigen  (hapten) specific, and recent experi- 
ments show that the factor carries determinants encoded by the I region (I-C) of the 
MHC  (J.  Moorhead and  C.  S.  David.  Unpublished  observations). Suppression  by 
SSF is genetically restricted (21). However, in contrast to other factors which carry I- 
region determinants and require I-region homology with the target cells to suppress, 
SSF-mediated suppression requires that the donors of DNFB-immune LN cells and of 
SSF share either the H-2K and/or the H-2D region of the MHC. Thus, acceptor or 
target molecules for SSF appear to be coded for by genes within the H-2K and H-2D 
loci. The purpose of the studies reported here was to investigate the nature of these 
acceptor sites.  The results indicate that the acceptor molecules for SSF are expressed 
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only on DNFB-immune T  cells and consist of histocompatibility antigens associated 
with the hapten dinitrophenol (DNP). The origin and role of these acceptor molecules 
is discussed. 
Materials  and  Methods 
Animals.  CBA, C57B1/10,  A/J, CaD2Fx, BI0.BR, and B10.D2 mice were purchased from 
The Jackson Laboratory, Bar Harbor, Maine. BALB/c mice were obtained from the AMC 
Cancer Research Center, Lakewood, Colo. A.TH, A.TL, and BI0.A(4R) mice were bred in our 
animal care facilities. 
Sensitization with DNFB or 2,4,2-trinitrocMorobonzeae (TNCB).  To serve as donors of DNFB- 
immune LN cells, mice were sensitized with DNFB (Eastman Kodak Co., Rochester, N. Y.) by 
two daily paintings of 25 #1 of 0.5%  DNFB on the clipped abdomen and 5 #1 on the footpads 
and ears. TNCB  (Matheson, Coleman, and Bell, Cincinnati, Ohio) sensitivity was induced by 
a single painting of 100 ~  of 7% TNCB on the clipped abdomen and 5 #1 on the footpads and 
ears. DNFB-immune LN cells were taken 3 d after the last painting, whereas TNCB-immune 
LN cells were taken 4 d after the single painting. 
Transfer of contact sensitivity.  3  d  after sensitization with  DNFB, single cell suspensions of 
draining LN were prepared and 4  X  107 to 5  X  107 cells injected i.v. into normal syngeneic 
recipients. The recipients and negative controls were challenged within 1 h after cell transfer by 
applying 20 ~1 of 0.2% DNFB on the dorsal side of each ear. Increased ear swelling (6") was 
measured 24 h later with an engineer's micrometer and expressed in units of 10  -4 in. 
Antisera.  Anti-H-2  d and anti-H-2  k were produced in C57BI/10 mice immunized with spleen 
and LN cells from B10.D2 or B10.BR mice, respectively. Anti-Ia  k was produced in A.TH mice 
by immunizing with A.TL spleen cells. The specificity and cytoxicity of this serum has been 
previously described (22).  Anti-H-2D  d ([B10.AKM  ×  A.SW]Fx anti-A.TH) and  anti-H-2K  k 
(A.TL anti-A.AL) were kindly provided by Dr.  Chella David. Anti-DNP was produced in 
BALB/c mice by three immunizations with DNP coupled to rabbit gammaglobulin (DNPa0- 
RGG) emulsified in Freund's complete adjuvant  (FCA). Anti-trinitrophenol (TNP)  was pro- 
duced in rabbits by three imnfunizations with TNPa~-RGG emulsified in FCA. Anti-brain- 
associated-0 (anti-BA-0) was produced in rabbits according to Goluh (23).  Before use, the anti- 
DNP and anti-TNP sera were extensively adsorbed with mouse spleen, thymus, and LN cells 
and the anti-BA-0 serum was adsorbed with mouse bone marrow and erythrocytes. The anti- 
H-2 sera were tested for specificity and cytotoxicity using a microassay described by Pincus and 
Gordon (24). 
Purification ofanti-DNP antibodies.  2 ml of BALB/c anti-DNP serum was slowly passed over 
5 ml of packed Sepharose beads (Pharmacia Fine Chemicals, Div. of Pharmaeia Inc., Piscata- 
way,  N.  J.)  conjugated  with  DNP~-KLH  and  the  column  then  washed  extensively with 
phosphate-buffered  saline  (PBS,  pH  7.2).  The  bound  antibodies were  eluted  with  0.1  M 
NH4OH,  the  eluate  neutralized  immediately  with  1  N  HCI,  dialyzed  against  PBS  and 
concentrated by filtration through an Amicon XMI00 membrane  (Amicon Corp., Scientific 
Sys. Div., Lexington, Mass.). To insure that functional antibody was recovered, the eluate was 
tested by primary binding using 3H-DNP-L-lysine (5 X  10  -s M  DNP) and by Ouchterlony gel 
diffusion using a variety of DNP conjugates. 
Preparation of Suppressor and Control Supernates.  Suppressor and control supernates were pre- 
pared as described in detail previously (20). Briefly, mice were injected i.v. on day 0 with DNBS 
(750 mg/kg) and on day 5, they were painted on the clipped abdomen with DNFB. The next 
day, peripheral and mesenteric LN cells were placed in culture (107 cells/ml) in RPMI-1640 
medium supplemented with serum and antibiotics. After 48 h, ceil-free  supernates were collected 
and  stored at  -20°C.  Control  supernates were prepared from  mice not  injected with  2,4- 
dinitrobenzene sulfonate (DNBS) but which were painted with DNFB. 
Purification of DNFB-immune  LN T and B  cells.  Purified T  cells were prepared by passing 
immune LN cells through a nylon wool column as previously described (22) according to the 
method of Julius et al. (25).  Nonadhercnt cells were collected and monitored for B cells and 
macrophages by immunofluorescent staining using fluorescein-labeled polyvalent rabbit anti- 
mouse  Ig  (RAMIg)  and  esterase staining, respectively. In  three  replicate experiments, the 
purified T  cells contained 0-2% B cells and <1% macrophages. 1434  SUPPRESSION  OF SENSITIVITY BY  SOLUBLE  FACTOR 
Populations enriched in B cells were prepared by treating immune LN cells with anti-BA-0 
serum (10  s cells/ml of 1:10 diluted serum, 4°C for 30 min) plus guinea pig complement (10  s 
cells/ml  of  1:6  serum,  37°C  for  30  min).  Dead  cells  were  removed  by  Ficoll/Isopaque 
(Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.)  gradient centrifugation (26).  Interface 
cells were collected, viable cells determined by trypan blue dye exclusion, and B cells enumerated 
by immunofluorescent staining with RAMIg. In two replicate experiments, >96% of the cells 
were viable of which >80% were Ig  +. 
Preparation of  Peritoneal  Exudate Cells.  Peritoneal exudate cells were induced by intraperitoneal 
injection of 3 ml of thioglycollate medium. The cells were harvested by lavage 4 d  later. The 
cells were 98% macrophages, as judged by esterase staining. 
Preparation of Adsorbing LN Cells.  Because  large  numbers  of  LN  cells  were  needed  for 
adsorption studies, T-cell-enriched, rather than purified populations, were prepared. This was 
done by suspending normal or immune LN cells in RPMI-1640 (Grand Island Biological Co., 
Grand  Island,  N.Y.)  medium  supplemented  with  5%  fetal calf serum  and  antibiotics and 
incubating the cells for 90 min at 37°C on plastic tissue culture dishes (Falcon Labware, Div. 
of Becton,  Dickinson,  &  Co.,  Oxnard,  Calif).  Nonadherent  cells were  recovered by gentle 
washing with warm medium. Cell recovery ranged from 65 to 80%. Immunofluorescent staining 
of the cells showed a depletion of Ig  + cells from 25 to 30% in the starting population to 10% or 
less. Esterase-positive cells decreased from  12 to 15 to 5% or less. Thus, as a result of depletion 
of both Ig  + cells and adherent macrophages, a cell population which was enriched in T  cells 
was obtained. 
Adsorption of Supernates.  5 ml of suppressor supernate was incubated with 2 ×  l0  s LN cells 
or l0  s macrophages for  1 h at 37°C with intermittent mixing. In some experiments, the cells 
were pretreated with antiserum (see Results) for 1 h at 4°C and then washed before being used 
for adsorption. The supernates were cleared by centrifugation and tested for suppressor activity 
on freshly prepared DNFB-immune LN cells. 
Treatment oflmmune LN Cells with Supernate.  DNFB-immune LN cells were incubated with 5 
ml  of control, suppressor or adsorbed suppressor su~ernatant  (5  ×  107 cells/ml) for  1 h  at 
37°C. The cells were then washed twice and 4-5 ×  10  cells injected i.v. into normal syngeneic 
recipients. Ear challenge and measurement of ear swelling were done as previously described. 
The suppressor effect of SSF was determined by its ability to suppress the expression of CS by 
the transferred LN cells. The suppressor activity of the adsorbed supernate was then compared 
to the suppressor activity of the unadsorbed supernate and the results expressed as the percent 
suppressor activity removed by adsorption. 
Results 
Suppression of Purified DNFB-immune  T Cells by SSF.  Initial experiments were done 
to  determine  if T  cells could  interact  with  and  be suppressed  directly by  SSF.  To 
accomplish this, LN  cells were  prepared  from  DNFB-immune  BALB/c mice and  a 
portion of the cells were purified on  nylon wool columns.  Unseparated and purified 
T  cells were  then  incubated with  BALB/c-derived control or suppressor supernate, 
washed, and transferred to normal syngeneic recipients. In this and all other experi- 
ments,  the  suppressor  effect  of SSF  was  determined  by  its  ability to  suppress  the 
expression of CS  by LN  cells from  DNFB-immune  mice that  were  transferred  into 
normal syngeneic recipients. Results of two experiments are shown  in Table I. Both 
unseparated LN cells and purified T  cells transferred CS. Both cell populations were 
suppressed equally by SSF. These results indicate that DNFB-immune T  cells express 
the acceptor molecules for SSF and interact directly with the factor. 
Cyclophosphamide (Cy) Pretreatment of Donors of DNFB-immune  LN Cells Does Not Alter 
Their  Sensitivity to  SSF-mediated Suppression.  Recent  studies  in  our  laboratory  have 
identified a subset ofT cells in DNFB-immune mice which are required for suppression 
of  the  efferent  limb  of  contact  sensitivity  by  suppressor  T  cells  (27).  This  cell 
population  is  found  only  in  DNFB-immune  mice,  it  is  IJ +  and  its  precursors  are JOHN  W.  MOORHEAD 
TABLE I 
Suppression of Purified DNFB-Immune  T Cells by SSF* 
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Supernate 
DNFB-immune  Exp. 1  Exp. 2 
LN cells trans- 
ferred  A Ear swelling:[:  Suppression  ,~ Ear swelling  Suppression 
×  10-4in  :lz SEM  %  ×  lO-4in  :1: SEM  % 
Control  Unseparated  34.4 ± 2.3  39.4 :t: 3.3 
Suppressor  Unseparated  1.7 ± 0.6  95  8.3 -i- 1.9  79 
Control  Purified T cells  31.6 :t: 3.1  34.1 :l: 2.7 
Suppressor  Purified T cells  1.8 :l: 1.3  94  6.0 +  1.1  82 
* Unseparated LN cells (24% Ig  ÷ in Exp. 1 and 19% Ig  ÷ in Exp. 2) and nylon wool purified LN T cells (0% 
Ig  + in Exp.  1 and 2% Ig  ÷ in Exp. 2) from DNFB-immune  BALB/c mice were treated in vitro with 
BALB/c-derived control or suppressor supernate and transferred to normal syngeneic recipients. Increased 
ear swelling was measured 24 h later as an index of transfer of contact sensitivity. 
:~ Ear swelling in recipients of immune cells minus ear swelling in negative controls (ear challenge only). 
sensitive to Cy. We have called these cells auxiliary T-suppressor cells (Ts-aux). Ts- 
aux is distinct from the effector T-cell population (TDn)  which is Ia- (22) and whose 
precursors  are  insensitive to Cy  (27,  28).  Because  Ts-aux  has  an  obligatory role in 
suppression by one type of suppressor T  cell, experiments were done to determine if 
it was also required for suppression by SSF. BALB/c mice were injected i.v. with 200 
mg/kg  Cy,  a  dose  which  removes  all  Ts-aux  activity  (27).  Control  mice  received 
saline. 2  d  later, all of the mice were sensitized with  DNFB.  Immune  LN cells were 
prepared 4 d  later, treated in vitro with BALB/c control or suppressor supernate and 
transferred to normal syngeneic recipients. These recipients plus normal controls were 
then  ear challenged  and  the ear swelling was  measured  24  h  later.  Results of two 
experiments are given in Table II. Cy treatment of donors of immune LN cells had no 
effect on their sensitivity to suppression by SSF. Thus,  we conclude that  the Ts-aux 
population is not required for suppression of DNFB-immune T  cells by SSF. 
Ability of Various Cell Populations  to Adsorb SSF.  The results in Table I  indicate that 
DNFB-immune-purified T  cells can interact with SSF. To determine if other cells are 
able to interact with the factor, the adsorbing capacity of various cell populations was 
tested. BALB/c-derived suppressor supernates were adsorbed with whole LN cells, T- 
cell-depleted LN cells or macrophages from normal or immune syngeneic donors. The 
adsorbed  supernates  were  then  tested  for  suppressor  activity  on  freshly  prepared 
DNFB-immune BALB/c LN cells. The results are given in Table III. Of the five cell 
populations tested only DNFB-immune BALB/c LN cells adsorbed suppressor activ- 
ity. LN cells or macrophages from normal BALB/c mice or TNCB-immune  BALB/ 
c  LN had no absorbing activity. More important, depletion of T  cells from  DNFB- 
immune  LN cells eliminated the ability of the remaining cells to adsorb the factor. 
Similar results were obtained when CBA-derived suppressor supernates were adsorbed 
with various populations of cells from normal or immune CBA mice, i.e., only DNFB- 
immune, T-cell-enriched LN cells adsorbed the suppressor factor (results not shown). 
Collectively, these results indicate that  the only cells able to  interact  with  SSF are 
DNFB-immune T  cells. 
Genetic Restriction  of Suppressor  Factor  Adsorption.  As described previously, SSF-me- 
diated suppression of DNFB sensitivity requires that  the donor of immune  LN cells 
and of SSF share either the H-2K and/or  H-2D  region of the MHC  (21).  Thus,  to 
begin  to  investigate the  nature  of the acceptor sites for SSF, suppressor supernates 1436  SUPPRESSION OF SENSITIVITY BY  SOLUBLE FACTOR 
TABLE  II 
DNFB-Immune LN Cells from Cydophosphamide  Pretreated Donors are Suppressed by SSF* 
Supernate 
Pretreatment of 
donors of immune 
LN cells 
Exp. l  Exp. 2 
A Ear Swellingqk  Suppression  A Ear Swelling  Suppression 
×  10-4in  ±  SEM  %  ×  10-4in  3= SEAt  % 
Control  Saline  27.5 ± 2.6  29.4 ±  3.6 
Suppressor  Saline  9.1 3= 1.7  67  8.2 3= 2.3  72 
Control  Cyclophosphamide  24.9 3= 2.9  34.2 3= 3.7 
Suppressor  Cyclophosphamide  5.4 3= 0.6  78  7.0 ±  1.7  80 
* BALB/c mice were injected i.e. on day -2 with 200 mg/kg cyclophosphamide. Control mice received 
saline. On days 0 and 1, all the mice were sensitized with DNFB and immune LN cells were harvested on 
day 4. These cells were then treated with BALB/c control or suppressor  supernate and transferred  to 
normal syngeneic  recipients.  Increased ear swelling was measured 24 h later as an index of transfer of 
contact sensitivity. 
See footnote in Table I. 
TABLE  III 
Ability of Various Cell Populations  to Adsorb Suppressor Factor 
Suppressor  activity 
BALB/c supernate  Cells used to adsorb supernate  A Ear swelling:~  removed by ad- 
sorption 
×  lO-~in  3= SEM  % 
38.8 3= 3.7 
7.0 3= 1.3 
36.7 3= 2.4  93.5 
6.5 3= 2.0  0 
Control  None 
Suppressor  None 
Suppressor  DNFB-immune BALB/c LN 
Suppressor  T-cell-depleted DNFB-immune 
BALB/c LN 
Suppressor  TNCB-immune BALB/c LN  8.2 +  2.1  6.4 
Suppressor  Normal BALB/c LN  7.7 +  1.8  3.6 
Suppressor  Normal BALB/c macrophages  7.5 3= 2.3  3.2 
* 5 ml of suppressor  supernate was incubated with 2 ×  10  s LN cells or 10  s macrophages for  1 h at 37°C. 
The supernates  were then cleared by centrifugation and tested for suppressor  activity on freshly prepared 
syngeneic DNFB-immune LN cells. 
:~ See footnote in Table I. 
were adsorbed  with  DNFB-immune  LN cells from different  H-2 haplotype  mice. As 
before, the adsorbed supernates were tested for suppressor activity on freshly prepared 
DNFB-immune  LN cells from appropriate strains. All experiments have been done at 
least two times and representative results are given in Table  IV. 
In Exp.  1, BALB/c  suppressor supernate was adsorbed with syngeneic or allogeneic 
(CBA)  immune  LN  cells and  the supernatants  tested on  immune  BALB/c  LN cells. 
The  suppressor  factor  was  adsorbed  only  by  the  syngeneic  cells.  The  reciprocal 
experiment  with  respect  to  H-2K  and  H-2D  is shown  in  Exp.  2.  In  this case,  CBA- 
derived SSF  (which  was  tested on CBA-immune  LN cells) was  completely adsorbed 
by B10.BR-immune  LN cells (MHC  identical with CBA) but no adsorption occurred 
with  A.TL-immune  LN  cells  (the  I  region  was  identical  with  CBA).  The  results 
indicate  that  homology at  H-2K  and/or  H-2D  is required  for factor adsorption.  To 
explore this point  in  more detail, experiments  were done  in which  suppressor  super- 
nates were adsorbed  with immune  LN cells from mice sharing either the H-2D or H- 
2K region of the MHC  with  the factor-producing strain.  In Exp.  3, A/J  (H-2K k,  H- 
2Dd)-derived  supernate  was  adsorbed  with  four  different  immune  LN  populations JOHN  W.  MOORHEAD 
TABLE. IV 
Genetic Requirements  of Suppressor Factor Adsorption 
1437 
DNFB-immune LN  Suppression activity 
Exp.  Supernate  cells used to adsorb  A Ear swelling:l:  removed by adsorp- 
supernate*  tion 
X  lO-4in 4- SEM  % 
1  BALB/c control  None  31.6 4- 3.7 
BALB/c suppressor  None  3.7 4- 1.9 
BALB/e suppressor  BALB/c  31.1 ±  3.0  98.2 
BALB/c suppressor  CBA  5.2 ±  1.3  5.6 
CBA control  None  28.5 +  2.2 
CBA suppressor  None  4.9 4- 0.6 
CBA suppressor  BI0.BR  26.6 4- 3.3  92.0 
CBA suppressor  A.TL  5.1 ±  1.6  1.5 
A/J control  None  30.6 4- 2.5 
A/J suppressor  None  6.0 4-  1.9 
A/J suppressor  A]J  28.0 4- 2.2  89.5 
A/J suppressor  BALB]c  26.3 4- 3.9  82.6 
A/J suppressor  A.TH  26.9 ±  3.3  85.0 
A/J suppressor  C57BL/10  7.1 ±  0,9  4.8 
A/J control  None  35.2 4- 2.7 
A/J suppressor  None  8.6 4- 1.4 
A/J suppressor  A/J  33.7 4- 3.3  94.3 
A/J suppressor  CBA  32.6 4- 3.9  90.2 
A/J suppressor  B10.A(4R)  32.0 4- 3,7  88.0 
A/J suppressor  C57BL/10  10.2 4- 1.7  6.3 
CaD2F1 control  None  42.3 +  5.0 
CaD2FI suppressor  None  9.8 +  1.5 
CnD2F1 suppressor  CaD2F1  41.4 4- 2.9  97.2 
C3DzFI suppressor  BALB/c  38.9 4- 3.9  90.4 
CaD~FI suppressor  CBA  12.2 4- 2.3  7.5 
CsD~Ft control  None  39.3 +  4.1 
CsD2FI suppressor  None  7.7 +  2.6 
CaD2FI suppressor  CaD2FI  35.7 +  3.7  88.1 
CsD2F1 suppressor  CBA  37.2 -l- 4.1  93.4 
C3D~FI suppressor  BALB/c  9.1 +  0.9  5.5 
* 2 x  10  s DNFB-immune LN cells were used to adsorb 5 ml of suppressor supernate for 1 h at 37°C. The 
supernates were cleared by centrifugation and tested for suppressor activity on freshly prepared DNFB- 
immune LN cells. 
See footnote in Table I. 
and  then  tested  on  DNFB-immune  BALB/c  LN  cells  (H-2K d,  H-2Da).  Suppressor 
factor was adsorbed  equally well by immune  LN  cells from A/J  (syngeneic), BALB/ 
c  (IG-~H-2D  identical),  and  most  important,  A.TH  (H-2D  identical)  mice.  Com- 
pletely  allogeneic  cells  (C57B1/10)  did  not  adsorb  the  factor.  Similar  results  are 
shown in Exp. 4 with respect to the H-2K  locus. Here, A/J  (H-2K k, H-2D a) suppressor 
factor  was  adsorbed  and  then  tested  on  DNFB-immune  CBA  LN  cells  (H-2K k,  H- 
2Dk).  Factor adsorption  occurred  with immune  LN  cells from A/J  (syngeneic), CBA 1438  SUPPRESSION OF  SENSITIVITY BY SOLUBLE FACTOR 
(H-2K---~IE identical),  and  B10.A(4R)  (H-2K, IA identical)  mice but  not  with  LN 
cells from allogeneic C57B 1/I0 mice. Although B 10.A(4R) and CBA mice share both 
the H-2K and portions of the I region with A/J, adsorption of the factor is most likely 
occurring via the H-2K homology because A.TL LN cells which are syngeneic in the 
I  region with CBA do not  adsorb CBA factor (see Exp.  2).  Thus, the data indicate 
that identity at either H-2K or H-2D is both necessary and sufficient to adsorb the 
suppressor factor. 
Rich  et  al.  have  previously shown  that  Fl-derived  MLR  suppressor  supernates 
contain two distinct  populations of suppressor factors, one specific for each parental 
haplotype (29). To explore this possibility in the contact sensitivity system, suppressor 
supernate derived from CaD2F1  mice (H-2  k ×  H-2  d)  was adsorbed with immune LN 
cells from BALB/c (H-2  a) or CBA (H-2  k) mice and then tested for suppressor activity. 
In  Exp.  5,  the  F1  supernates  were  tested  on  DNFB-immune  BALB/c  LN  cells. 
Adsorption with BALB/c LN cells removed the suppressor activity whereas adsorption 
with  CBA  LN  cells  had  no  effect.  The  reciprocol  is  shown  in  Exp.  6.  Here  the 
supernates were tested on DNFB-immune CBA LN cells. Factor adsorption occurred 
with CBA LN cells but not with BALB/c LN cells. Thus, the data indicate that the 
F1 supernates contain  at least two suppressor factors, each specific for one parental 
haplotype and each specifically adsorbed by immune LN cells of that  relevant  H-2 
haplotype. 
Adsorption of Suppressor Factor is Blocked by  Treating Immune LN Cells with Antibodies 
against H-2K or H-2D  Determinants.  If H-2K and  H-2D  gene  products  on  DNFB- 
immune T  cells serve as target molecules for SSF, then blocking these determinants 
with  antibodies  should  inhibit  adsorption  of the  factor.  To  evaluate  this,  DNFB- 
immune LN cells were treated for  1 h  at 4°C  with  different  anti-H-2 reagents  (108 
cells/ml in  1:10 diluted  serum), washed,  and then used to adsorb suppressor super- 
nates. The supernates were then tested for suppressor activity on DNFB-immune LN 
cells  from appropriate strains.  In  all  experiments,  the  antiserum-treated  cells were 
monitored for antibody-binding by immunofluorescent staining with RAMIg. Results 
of these experiments are given in Table V. 
As shown  in  Exp.  1,  pretreatment  of immune  BALB/c  LN cells with  anti-H-2  d 
(B10  anti-B10.D2;  99%  of the cells were  found  positive by IF staining)  completely 
blocked  adsorption  of the  factor.  Treating  the  cells  with  NMS  had  no  effect  (9% 
positive by IF staining).  This experiment was repeated using immune CBA LN cells 
and CBA-derived suppressor factor (Exp. 2). Treating the immune cells with anti-H- 
2 k serum  (B10  anti-B10.BR;  96%  of the  cells  were  found  positive  by IF  staining) 
blocked factor adsorption.  In contrast,  treating the cells with anti-Ia  k serum  (A.TH 
anti-A.TL;  13% of the cells positive by IF staining compared with 7% in NMS-treated 
cells) had no effect. This suggests that the blocking by anti-H-2 serum is a  result of 
antibodies directed against gene products of the H-2K and H-2D loci, i.e.,  histocom- 
patibility antigens. To verify this, experiments were done using antiserum specific for 
H-2D  a or  H-2K  k determinants.  In  Exp.  3,  DNFB-immune  LN cells  from BALB/c 
mice (H-2D  d) were treated with NMS or anti-H-2D  a serum (10% of NMS treated and 
100% of antiserum-treated cells were positive by IF staining). The washed cells were 
then used to adsorb A/J suppressor factor which was then tested on freshly prepared 
BALB/c  DNFB-immune  LN  cells.  As  shown,  treating  the  cells  with  anti-H-2D  d 
completely blocked their ability to adsorb the factor. In Exp. 4, H-2K  k determinants JOHN  W.  MOORHEAD  1439 
TABLE  V 
Adsorption of Suppressor Factor by Immune  LN Cells is Blocked by Pretreatmg the Cells with Antibodies 
Against H-2K or H-2D Determinants 
DNFB-immune  Pretreatment of  Suppressor 
LN cells used  immune LN  A Ear swelling  S  activity re- 
Exp.  Supernate  to adsorb su-  cells before ad-  moved by 
pernate  sorption  *  adsorpt  ion 
3 
×  10 -4 in  ± SEM  % 
BALB/c control  None  None  44.2 ±  5.1 
BALB/c suppressor  None  None  7,3 ±  1.7 
BALB/c suppressor  BALB/c  NMS  40.2 ±  3.3  89,4 
BALB/c suppressor  BALB/c  Anti-H-2  d  8.2 ±  2.0  2.3 
CBA control  None  None  35.1 ±  3.7 
CBA suppressor  None  None  5.1 ±  1.7 
CBA suppressor  CBA  NMS  32.6 ±  4.1  91.2 
CBA suppressor  CBA  Anti-H-2  k  8.0 ±  1.6  8, l 
CBA suppressor  CBA  Anti-Ia  k  33.3 ±  2.9  94.0 
A/J control  None  None  33.4 ±  3.6 
A/J suppressor  None  None  7.0 ±  1.6 
A/J suppressor  BALB/c  NMS  28.7 ±  3.0  82,1 
A/J suppressor  BALB/c  Anti-H-2D  d  6.6 ±  1.1  0 
A/J control  None  None  26.7 ±  1.9 
A/J suppressor  None  None  2.4 ±  0.6 
A/J suppressor  CBA  NMS  26.4 ±  2.2  98.8 
A/J suppressor  CBA  Anti-H-2K  k  2.2 ±  1.0  0 
BALB/c control  None  None  41.9 ±  3.8 
BALB/c suppressor  None  None  8.0 ±  1.1 
BALB/c suppressor  CaD2F~  NMS  37.0 ±  2.8  85.6 
BALB/c suppressor  CnD2F1  Anti-H-2  a  7.4 ±  1.7  0 
BALB/c suppressor  CsD2F~  Anti-H-2  k  35.6 ±  3.6  81.5 
CBA control  None  None  32.3 +  3.3 
CBA suppressor  None  None  4.2 ±  0.7 
CBA suppressor  CsD2FI  NMS  29.5 ±  2.2  90.0 
CBA suppressor  CsD2F1  Anti-H-2  k  6,4 ±  0.4  7.8 
CBA suppressor  CaD2F1  Anti-H-2  d  27.7 ±  3.0  83.6 
* DNFB-immune LN cells were treated for 1 h at 4°C with NMS or anti-H-2 reagents. After washing, 2 
×  l0  s cells were used to adsorb 5-ml alliquots of suppressor supernate for  1 h at 37°C. The supernates 
were cleared by centrifugation and tested for suppressor activity on freshly prepared DNFB-immune LN 
cells. 
$ See footnote in Table I. 
were investigated. Immune  LN cells from CBA mice (H-2K k) were treated with NMS 
or anti-H-2K k  (6% of NMS-treated  and  99% of antiserum-treated  cells positive by IF 
staining) and then used to adsorb A/J-derived  suppressor factor. The supernates were 
tested on  DNFB-immune  CBA  LN  cells.  Treating  the  immune  CBA  LN  cells with 
anti-H-2K k completely  blocked  factor adsorption  by the cells.  These  results provide 
direct  evidence that  H-2K  and  H-2D  determinants  on  DNFB-immune  T  cells serve 
as target molecules for SSF. 1440  SUPPRESSION  OF  SENSITIVITY BY SOLUBLE FACTOR 
To verify the specificity of the serum blocking in a  more critical way, additional 
experiments were done in which F1 DNFB-immune LN cells were treated with anti- 
H-2 sera specific for each parental  haplotype. The washed cells were then  used to 
adsorb suppressor supernates which  were specific for one of the two haplotypes.  If 
specific blocking occurs,  then  F1  LN cells  treated  with  anti-H-2 serum  against  P1 
haplotype should not adsorb SSF directed against that haplotype. However, F1 cells 
treated with anti-H-2 serum against the P2 haplotype should adsorb the factor and 
vice versa. Results are shown in Exps. 5 and 6.  In Exp. 5, C3D&I immune LN cells 
(H-2  k X  H-2  a) were treated with either NMS, anti-H-2  a  (B10 anti-Bl0.D2), or anti- 
H-2  ~ (B10 anti-Bl0.BR)  serum  (7% of NMS-treated,  99% of anti-H-2a-treated, and 
100%  of anti-H-2k-treated cells were determined  positive by IF staining).  The cells 
were then used to adsorb BALB/c-derived suppressor factor which suppresses DNFB- 
immune T  cells expressing H-2K  a or H-2D  a determinants.  The adsorbed supernates 
were then tested for suppression using DNFB-immune BALB/c LN cells. Fx LN cells 
treated with anti-H-2  a were unable to adsorb the BALB/c suppressor factor. However, 
the Fx cells treated with either NMS or anti-H-2  k serum  (the irrelevant serum with 
respect  to  the  specificity of the  factor)  adsorbed  suppressor  activity  equally  well. 
Results of the reciprocol experiment are shown in Exp. 6. In this case, CBA suppressor 
supernates which suppress DNFB-immune T  cells expressing H-2K  k or H-2D  k deter- 
minants were adsorbed and tested on immune CBA LN cells. As shown, F~ LN cells 
treated  with  anti-H-2  k (97%  positive by IF staining)  were unable  to adsorb  CBA- 
derived suppressor factor. On the other hand,  F1 cells treated with anti-H-2  d serum 
(98%  positive by IF staining)  which  in  Exp.  5  were unable to adsorb the BALB/c 
suppressor factor, adsorbed the CBA suppressor factor equally as well as did NMS- 
treated cells (8% positive by IF staining). 
Adsorption  of Suppressor Factor is  Blocked  by  Treating  Immune  LN  Cells with  Anti- 
DNP.  SSF has affinity and specificity for the hapten DNP (20). Thus, the possibility 
was considered  that the antigen  specificity of SSF could be a  result of, in part, the 
presence of DNP  on  the  immune T  cell  membrane, associated  in  some way with 
histocompatibility antigens.  If so, then  treating DNFB-immune LN cells with  anti- 
DNP  antibodies  should  block  their  ability  to  adsorb  the  suppressor  factor.  To 
investigate this, DNFB-immune BALB/c LN cells were treated with either NMS (108 
cel!s/ml in  1:10 dilution)  or affinity purified mouse anti-DNP antibodies  (108 cells/ 
ml,  25  #g anti-DNP/ml)  for  1 h  at  4°C.  The cells were then  washed  and  used to 
adsorb BALB/c-derived suppersson factor which was then tested on DNFB-immune 
BALB/c LN cells. The results are shown in Table VI. As shown in Exp.  1, treating 
the immune LN cells with anti-DNP antibodies completely blocked the adsorption of 
the suppressor factor.  Similar experiments were done using whole anti-TNP serum 
prepared  in  rabbits  (Exp.  2).  Treating  with  anti-TNP  serum  also  blocked  the 
adsorbing capacity of the immune LN cells. To control for possible nonspecific steric 
inhibition,  immune  LN  cells  were  pretreated  with  rabbit  anti-BA-0  serum.  This 
serum, although  binding to >80% of the LN cells as measured by IF staining with 
fluorescein-labeled goat anti-rabbit Ig, did not block the adsorption of SSF. 
Discussion 
Previous studies on SSF-mediated suppression of contact sensitivity have indicated 
that the acceptor or target molecules on DNFB-immune LN cells for the suppressor JOHN  W.  MOORHEAD  1441 
TABLE VI 
Adsorption of Suppressor Factor by Immune LN Cells is Blocked by Pretreating the Cells with Antibodies 
Against DNP or TNP 
DNFB-immune  Pretreatment  of  Suppression 
Exp.  Supernate  LN cells used  activity re-  to adsorb su-  LN cells before  A Ear swelling:~  moved by 
pernate  adsorption*  adsorption 
×  I0 -4in ++- SEM  % 
BALB/c control  None  None  37.4 ± 3.9 
BALB/e suppressor  None  None  9.0 ±  1.6 
BALB/e suppressor  BALB/e  NMS  34.8 __. 2.6  90.8 
BALB/c suppressor  BALB/c  Anti-DNP  9.4 ±  1.2  1.5 
BALB/c control  None  None  43.6 ± 4.1 
BALB/c suppressor  None  None  10.2 ___ 1.7 
BALB/c suppressor  BALB/c  NRS  37.5 ± 2.9  81.8 
BALB/c suppressor  BALB/c  Anti-TNP  12.0 ± 0.6  5.8 
BALB/c suppressor  BALB/c  Anti-BA-0  41.4 ± 3.3  93.4 
*  DNFB-immune BALB/c LN cells were incubated  for 1 h at 4°C with either NMS or anti-DNP (Exp. 1) 
or NRS, anti-TNP or anti-BA-0 (Exp. 2). After washing, 2 ×  108 cells from each cell suspension were 
used to adsorb 5-ml alliquots of suppressor supernate  for 1 h at 37°C. The supernates were cleared by 
centrifugation and tested for suppressor activity on freshly prepared syngeneic DNFB-immune LN cells. 
:~ See footnote in Table I. 
factor are coded for by genes in the H-2K and/or H-2D regions of the MHC  (21). In 
the present study, adsorption experiments were done to investigate the nature of these 
acceptor molecules and to determine the cell type(s) on which they are expressed. The 
experimental  results  establish  the  following  points:  (a)  Purified  LN  T  cells  from 
DNFB-immune  mice express acceptor molecules for SSF;  (b)  pretreating mice with 
Cy before sensitization with DNFB does not alter the sensitivity of immune LN cells 
from these mice to suppression by SSF;  (c) acceptor molecules for SSF are expressed 
only on DNFB-immune T  cells. Normal T  cells, macrophages, T  cell-depleted DNFB- 
immune LN cells (B cells), or TNCB-immune  LN cells do not absorb the suppressor 
factor and thus, do not express the target molecules; (at) for DNFB-immune T  cells to 
adsorb the factor, they must share either the H-2K or H-2D region of the MHC  with 
the factor-producing strain; and  (e) factor adsorption can be blocked by treating the 
immune T  cells with  antibodies specific for H-2K or H-2D  determinants or for the 
hapten DNP. 
The finding that  purified populations of immune LN cells are suppressed by SSF 
indicates that T  cells can interact directly with the factor. This conclusion is supported 
by the experiments which showed that immune T  cells are the only cell type capable 
of adsorbing the suppressor activity. Furthermore,  pretreatment  of mice with  Cy at 
doses known to eliminate precursors of suppressor cells (28)  and suppressor amplifier 
(30)  or suppressor auxiliary ceils (27)  does not alter the sensitivity of DNFB-immune 
T  cells from these animals to suppression by SSF. Thus,  it appears that suppression 
is  mediated  by interaction  of the  factor with  immune  LN  T  cells. We  believe this 
interaction  occurs directly with  the effector T-cell population  and  does not  require 
the participation of other T-cell subsets. 
These results differ from previous reports by Zembala and Asherson (2) and more 
recently by Ptak et al. (31) concerning their studies on the suppressor factor for TNCB 1442  SUPPRESSION  OF SENSITIVITY BY SOLUBLE FACTOR 
contact  sensitivity.  These  investigators  have  shown  that  this  factor  is  completely 
adsorbed by normal peritoneal macrophages which are then able to suppress TNCB- 
immune T ceils. Both living and heat-killed macrophages are able to adsorb the factor 
and adsorption is inhibited by blocking the macrophage Fc receptor with aggregated 
IgG. In addition, syngeneic, allogeneic and xenogeneic macrophages adsorb the factor 
equally well. My results show that macrophages do not adsorb the suppressor factor 
specific for DNFB contact sensitivity (Table III). Cell numbers as high as 50  X  10  6 
macrophages/ml  have  been  used  with  no  detectable  loss  of suppressor  activity. 
Furthermore, macrophages which have been used to adsorb the supernates are not 
suppressive when  cotransferred with  DNFB-immune  LN cells to normal  recipients 
(not shown). 
An  explanation  for these different findings  is  not  readily apparent.  However, it 
should  be  noted  that  although  the  DNFB  and  TNCB  factors  are  produced  in 
essentially the same way, significant differences between them are known to exist. For 
example, SSF cannot be adsorbed by anti-DNP or -TNP affinity columns (20) whereas 
the TNCB factor is adsorbed by, and can be recovered from, the same columns (our 
unpublished  results  and  personal  communication  from  Mark  Greene and  Robert 
Cone). The TNCB factor has been shown to carry determinants encoded by genes in 
the I-J region of the MHC  (11);  i.e., it is specifically adsorbed by affinity columns 
conjugated with anti-IJ antibodies.  We have confirmed this  finding but have been 
unable  to adsorb  SSF  on the same  columns.  Rather,  SSF  is  adsorbed  by columns 
conjugated with antibodies specific for I-C region determinants (J. W. Moorhead and 
C.  S.  David. Unpublished observations.).  Finally, suppression by SSF is genetically 
restricted (21). No restrictions for suppression by the TNCB factor have been reported. 
Thus, the dichotomy with respect to adsorption by macrophages may be yet another 
difference between the factors and their mode of action. However, at the present time, 
we cannot rule out a  possible role for macrophages in SSF-mediated suppression.  It 
is possible that after SSF is bound to T  cells, certain conformational changes occur in 
the molecule such that macrophages can not bind the factor. This would be similar 
to changes which are known to occur in the Fc portion of IgG antibodies following 
binding to antigen.  Such an interaction may have an essential  role in the ultimate 
suppression of the immune T cells. Experiments to explore this possibility are currently 
in progress. 
For enriched populations of DNFB-immune T  cells to adsorb SSF, identity at the 
H-2K and/or H-2D region of the MHC is required between the donor of the immune 
T  cells and  the  donor of the  factor.  These restrictions coincide precisely with  the 
genetic  requirements  for suppression  (21).  The  essential  role of histocompatibility 
determinants was further shown in the blocking experiments. Antibodies specific for 
H-2K or  H-2D antigens  completely blocked the  ability of immune  LN T  cells  to 
adsorb  the  factor, whereas  antibodies  against  Ia  or 0-antigens  had  no effect. This 
blocking of adsorption  is highly specific. F1  DNFB-immune  LN cells,  treated with 
anti-H-2 serum specific for the P1 haplotype, were unable to adsorb SSF specific for 
that  haplotype.  However, Ft  cells  treated  with  anti-H-2  serum  specific for the  P2 
haplotype, adsorbed the Pt suppressor factor as well as Ft cells treated with  NMS. 
Similar results were obtained with suppressor factor specific for the Pz haplotype, i.e., 
FI  LN cells treated with  anti-H-2  specific for P2  haplotype did  not  adsorb  the  P2 
factor, whereas Ft cells treated with anti-H-2 specific for Pt were not inhibited. These JOHN W.  MOORHEAD  1443 
results provide strong evidence that histocompatibility antigens play an integral and 
essential role in the binding of SSF. 
Nevertheless, histocompatibility antigens alone do not serve as the target molecules 
for SSF. This was shown in two ways. First, syngeneic populations of normal LN cells, 
T  cell-depleted DNFB-immune LN cells and TNCB-immune LN cells, all of which 
express the relevant histocompatibility antigens, do not adsorb the suppressor factor. 
Second  and  more  important,  treatment  of T-cell-enriched populations of DNFB- 
immune LN cells with anti-DNP or -TNP antibodies blocks their ability to adsorb 
the suppressor factor. Because these antisera were extensively adsorbed with normal 
lymphocytes before use and the antibodies for one serum were purified on a  DNP- 
affinity column, their ability to block factor adsorption indicates that the immune T 
cells have DNP on their surface. Together with the blocking by anti-H-2 antibodies, 
these results indicate that the target molecules on DNFB-immune T  cells for SSF are 
comprised of histocompatibility antigens associated with the hapten DNP. 
These data are quite similar to previous reports by Schmitt-Verhulst et al. (32) and 
Burakoff et  al.  (33)  concerning cytolytic T  cells  induced  in  vitro against  hapten- 
modified autologous lymphocytes. These authors have shown that lysis by the T  cells 
is inhibited by pretreating the target cells with antibodies directed against either the 
histocompatibility antigens or the hapten. Thus, it appears that these cytolytic T  cells 
and SSF recognize similar determinants on the membranes of their respective target 
cells.  This similarity might indicate that SSF actually represents soluble cytolytic T 
cell receptors shed in vitro by the cultured  LN cells.  This seems unlikely, however, 
because  recent  experiments  in  our  laboratories  indicate  that  cytolytic T  cells  are 
neither present in mice, nor can they be induced in cultures of LN cells from mice, 
treated  in  ways similar  to  those  used  to  induce  SSF  (R.  Cleveland.  Unpublished 
results.). 
The ability of either anti-H-2 or anti-DNP  antibodies alone to block adsorption 
indicates that the factor must bind or recognize both moieties simultaneously. We do 
not know, however, whether the factor is monovalent and recognizes DNP and H-2 
as a  single determinant, i.e., like altered-self, or divalent and  recognizes the two as 
independent determinants. 
Several experimental findings must  be considered in analyzing this question. We 
have previously shown  that  SSF  is  adsorbed  by DNP-KLH affinity columns  (20). 
Thus, the factor has affinity for DNP alone which suggests that it has a  receptor or 
receptors specific for DNP.  However, DNFB-immune  LN cells allogeneic with  the 
factor-producing strain are not suppressed by (20,  21), and do not adsorb, the factor 
even though they carry DNP on their surface, i.e., the T  cells have the right hapten 
but the wrong H-2 antigens. This would seem to favor single determinant recognition 
although lack of adsorption in this case may also involve hapten density (see below). 
We have attempted to resolve this by adsorbing supernates with normal LN lympho- 
cytes coupled in vitro with DNP (34).  These cells contain ~2-3 gg of DNP/107 cells 
and we have used  2.5  ×  107 cells to adsorb  5  ml of supernate.  Thus far, we  have 
found that DNP-lymphocytes have an adsorption profile exactly like DNFB-immune 
LN cells. That is, DNP-syngeneic lymphocytes (syngeneic with the factor-producing 
strain)  completely adsorb  the  factor whereas  DNP-allogeneic  lymphocytes do  not 
adsorb  the  factor  (J.  W.  Moorhead.  Unpublished  observations.).  These  findings 
indicate that adsorption by DNP-syngeneic lymphocytes, like adsorption by DNFB- 1444  SUPPRESSION OF SENSITIVITY BY SOLUBLE FACTOR 
immune T  cells, involves more than factor recognition of hapten alone. 
To reconcile these apparent contradictory findings, I have formulated the following 
working hypothesis with respect to the factor and its binding requirements: the factor 
is a multivalent molecule with at least two receptor sites specific for DNP and at least 
one  receptor  site  specific  for  H-2.  For  the  factor  to  form  a  stable  bond  with  its 
respective target molecules, at least two receptor sites must be occupied.  In the case 
of syngeneic DNFB-immune T  cells or syngeneic DNP-labeled LN cells, this require- 
ment is satisfied by the factor binding to DNP and H-2 determinants. For DNP-KLH 
affinity columns, binding occurs via two receptors for DNP. This is possible because 
of the high density of DNP molecules on the protein carrier. The factor does not bind 
to  allogeneic  DNFB-immune  T  cells  or  allogeneic  DNP-labeled  LN  cells  because 
simultaneous binding of the two receptors does not occur. The H-2-specific receptor 
does not bind because the wrong H-2 is expressed by the ceils. Two receptors for DNP 
are not occupied because that  hapten density on the cell surface is not sufficient to 
allow the necessary cross-linking. 
An interesting question raised by the blocking studies in this report has to do with 
the origin  and  function  of the  hapten  DNP which  is  present  on  the surface of the 
immune T  cells.  It is not  generally thought  that  immune T  cells carry membrane- 
bound antigen. There are at least two possible explanations for this finding. First, as 
a  result  of the  highly  reactive nature  of the  antigen,  DNFB,  it  is  possible that  the 
hapten is bound directly to the cell surface. The association with histocompatibility 
antigens would then occur as a  random event. All LN cells, rather than just T  cells, 
should then have hapten bound to their membrane and should be able to adsorb the 
factor. The experiments in which T-cell-depleted LN cells from DNFB-immune mice 
failed to adsorb the suppressor molecules indicate that this is not the case. 
An alternative explanation that we think best explains the data is that a complex 
of hapten plus histocompatibility determinants, shed by other cells, is passively bound 
to  the  membrane  of the  immune  T  cells.  We  believe  that  during  the  process  of 
immunization  with  DNFB,  antigen-presenting  cells  (macrophages?)  shed  small 
amounts of soluble membrane material, i.e., DNP complexed with H-2 determinants. 
Immune T  cells  then  bind  this  material  via some of their  antigen  receptors.  The 
bound complexes serve as targets for the suppressor factor thus rendering the T  cells 
sensitive to this form of immunoregulation. Because the complex serves only to focus 
the suppressor factor on the T  cells, immune cells which do not have the complex on 
their  surface would  be insensitive  to  SSF-mediated  suppression  but  should  still  be 
able to transfer immunity. Recent unpublished  results in my laboratory support this 
model. DNFB-immune LN cells, after overnight culture in vitro, are able to transfer 
contact  sensitivity at  levels comparable to  freshly prepared LN cells.  However, the 
cultured LN cells are not suppressed by SSF nor are they able to adsorb the suppressor 
activity from the supernates. 
This model is similar, at the T-cell level, to recent findings by Warren and Davie 
(35). They were able to show that high affinity antibody-producing cells are suppressed 
by carrier-specific suppressor T  cells only if the hapten carrier complex is bound to 
the B-cell surface. In addition, numerous reports have shown that antigenic material 
shed from cell membranes is bound by immune T  cells. For example, Erb et al.  (36) 
reported that macrophages incubated with soluble antigen  in vitro release a  soluble 
material  which  is  capable of inducing  helper  T  ceils.  This  material  was  found  to JOHN W.  MOORHEAD  1445 
consist  of I-region-coded products  and  antigenic  fragments.  Nagy et  al.  (37)  have 
shown that T  cells activated in mixed lymphocyte reactions have either K- or I-region 
alloantigenic products bound to their surface. Elliott et al. (38)  further demonstrated 
that the bound fragments could be removed from the blast cells by trypsin treatment 
and,  after a  recovery period,  the  cells were  able  to  specifically bind  fresh,  soluble 
alloantigens.  This finding was recently confirmed and  extended  by Krammer (39) 
who showed that soluble alloantigens and anti-idiotypic antibodies compete for the 
same site on the activated T  cells. This site is most likely the specific T-cell receptor. 
Summary 
Previous studies have shown that suppression of 2,4-dinitrofluorobenzene  (DNFB) 
contact  sensitivity  by  soluble  suppressor  factor  (SSF)  requires  that  the  donor  of 
immune  lymph  node  (LN)  cells  and  of SSF  share  either  the  H-2K and/or  H-2D 
region of the major histocompatibility complex. Thus, target or acceptor molecules 
for SSF appear to be coded for by genes within the H-2K and H-2D loci. Experiments 
were done to investigate the nature of these target molecules and to determine what 
cell types expressed them. It was found that purified lymph node T cells are suppressed 
by SSF indicating that T  cells express the acceptor molecules. Adsorption experiments 
showed  that  the  only cells  capable of adsorbing  the  suppressor  factor are  DNFB- 
immune T  cells from donors which share with the factor-producing strain either the 
H-2K or H-2D locus. This adsorption can be specifically blocked by pretreating the 
immune LN cells with antibodies directed against H-2K and/or H-2D determinants 
or against the hapten DNP but not by antibodies against Ia or 0-antigens. Collectively, 
these results indicate that the target molecules are expressed only by DNFB-immune 
T  cells and are comprised of histocompatibility antigens associated with DNP. 
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